SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-12-039830
Filing Date
2012-05-24
Accepted
2012-05-24 16:05:53
Documents
4
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a12-12649_110ka.htm 10-K/A 261692
2 EX-10.34 a12-12649_1ex10d34.htm EX-10.34 135050
3 EX-31.1 a12-12649_1ex31d1.htm EX-31.1 13592
4 EX-31.2 a12-12649_1ex31d2.htm EX-31.2 14088
  Complete submission text file 0001104659-12-039830.txt   425498
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 12867522
SIC: 2834 Pharmaceutical Preparations